IPC Flags ADR Risks with Polymyxin B, Clomipramine, Famotidine Susmita Roy3 May 2026 6:57 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), in its latest drug safety alert for March 2026, has reported safety signals indicating that the...
Enzene Biosciences Gets SEC Approval to Conduct Phase III Pembrolizumab Trial Parthika Patel1 May 2026 10:30 AM ISTNew Delhi: Enzene Biosciences Ltd has received recommendation from the Subject Expert Committee (SEC), under CDSCO, for grant of permission to conduct...
Roxithromycin NSQ Case: Telangana HC Slams CDSCO for 'Mindless' Prosecution, Imposes Rs 50,000 Cost Susmita Roy30 April 2026 8:25 PM ISTTelangana: In a sharp rebuke underscoring the need for accountability in regulatory action, Justice Jukanti Anil Kumar of the Telangana High Court...
DCGI Approves Zydus' Phase III Trials for Zintrodiazine to Combat Drug-Resistant Malaria Parthika Patel27 April 2026 6:05 PM ISTAhmedabad: Zydus Lifesciences Limited has received approval from the Drugs Controller General of India (DCGI) to initiate Phase III clinical trials of...
CDSCO Panel Asks Akums to Conduct PK/PD Study for High-Dose Vitamin D3 Injection with Added Subjects Susmita Roy26 April 2026 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has asked Akums Drugs &...
48 Drug Batches Fail Quality Tests in CDSCO's March 2026 NSQ Alert Susmita Roy23 April 2026 11:45 AM ISTNew Delhi: In a fresh drug safety alert underscoring continued regulatory vigilance, 48 batches of drugs, medical devices, and allied products have...
Suspected Spurious Buprenorphine Injection Batch Under Scanner, CDSCO Launches Investigation Susmita Roy22 April 2026 11:45 AM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued an alert regarding an additional drug batch, with preliminary findings...
CDSCO Reorganises Workforce, Transfers 95 Officials Amid Rising Compliance Concerns Parthika Patel21 April 2026 11:45 PM ISTNew Delhi: In a major administrative move aimed at strengthening regulatory oversight and improving efficiency, the Central Drugs Standard Control...
Govt Panel Tightens Prescription Norms, Brings 4 Drugs Under Schedule H1, Retains Dicyclomine in Schedule H Susmita Roy21 April 2026 11:45 PM ISTNew Delhi: In a significant regulatory move aimed at curbing drug misuse and intoxication, the Drugs Consultative Committee (DCC) has approved the...
No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs Susmita Roy18 April 2026 8:51 PM ISTNew Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against...
DCGI Pushes Reforms, Drug Approvals Now Within 150 Days Susmita Roy16 April 2026 8:51 PM ISTNew Delhi: India's drug regulatory authority has significantly cut down approval timelines by more than 50% and simplified several key regulatory...
Sanofi's Thyrotropin Alfa Label Update: CDSCO Panel Recommends New Prescription Warning, Limits Sale to Specialists Only Susmita Roy12 April 2026 11:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has approved an amendment in the warning...
